Five takeaways from its financial results released May 5:
1. Net sales were $271.2 million. That’s a 4.4 percent increase compared to the same period last year. The increase was credited to month-over-month improvement in U.S. procedural volumes and low double-digit international growth.
2. The company saw a GAAP net loss of $7.5 million, or diluted loss per share of $0.15.
3. NuVasive had a non-GAAP net income of $19 million, which is down 25.2 percent compared to the first quarter last year.
4. NuVasive retired $650 million of convertible debt at maturity and funded the $150 million payment to acquire Simplify Medical.
5. The company has seen positive feedback on the Simplify Medical acquisition, and it plans to launch the Pulse platform later this year.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
